Follow-Up and Monitoring
Continued follow-up and monitoring are essential for individuals with aplastic anemia, even after achieving remission. As the exact cause and progression of this condition are still unclear, there is a risk of recurrence. Additionally, there is a known association between aplastic anemia and paroxysmal nocturnal hemoglobinuria. Research indicates a potential overlap between these two conditions, prompting medical professionals to closely monitor former aplastic anemia patients. This ongoing monitoring ensures that prompt and responsive treatment can be provided if paroxysmal nocturnal hemoglobinuria develops.
Prognosis of Aplastic Anemia
Aplastic anemia can be life-threatening if left untreated. However, new research indicates that with proper treatment, the five-year survival rate for individuals under the age of 40 is estimated to be between 70% and 80%. For those over the age of 40, the survival rate drops slightly to 50%. It is important to note that the chances of survival increase significantly if the person is able to find a well-matched stem cell donor.
It is not uncommon for relapses to occur in aplastic anemia cases, and individuals who undergo transplant treatments may also experience graft-versus-host disease. This condition arises when the body’s immune system attacks the newly transplanted stem cells, leading to various medical complications. As a result, long-term monitoring of aplastic anemia is essential for managing the disease effectively.